This study assessed two different dosages of an investigational Zika Virus vaccine (Ad26.ZIKV.001) in healthy adults. The main purpose was to determine if the study vaccine was safe and if any reactions occurred. The study closed enrollment in September 2018. Data analysis is underway.
Center for Virology and Vaccine Research
3 Blackfan Circle
Boston, MA 02115 – USA
CVVR Clinical Trials Unit